In the past 12 months, the United States has seen a sharp and alarming rise in vaccine-preventable diseases (VPDs), signaling both a public health crisis and a strategic inflection point for pharmaceutical companies.

At the same time, public sentiment is beginning to shift—54% of Americans now say that media coverage of local outbreaks has changed their views on vaccines, creating a renewed window of opportunity for pharma to lead with science, rebuild trust, and reengage the public in the value of immunization.

 

For the full brief, click the "Download Now" button below.

 

Want to learn more about our unique individualized patient engagement solutions?

Contact Us